Vitamin D Replacement and Type 2 Diabetes Mellitus

被引:18
作者
Issa, Claire. M. [1 ]
Zantout, Mira S. [1 ]
Azar, Sami T. [1 ]
机构
[1] Amer Univ, Beirut Med Ctr, Div Endocrinol & Metab, Dept Internal Med, 3 Dag Hammarskjold Plaza,8th Floor, New York, NY 10017 USA
关键词
25 hydroxy vitamin D; type 2 diabetes mellitus; vitamin D replacement; 25 hydroxy vitamin D deficiency; diabetes control; diabetes complications;
D O I
10.2174/1573399811666141210153503
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this paper is to review the evidence testing the possible benefit of vitamin D replacement on diabetes control and complications. Type 2 diabetes mellitus (DM 2) has become a significant global health care problem and its reported incidence is increasing at an alarming rate. Despite the improvement in therapy and development of new drugs, treatment is still not optimal especially with the associated adverse effects of most of the available drugs. New efforts are shifted toward disease prevention and a search for safer drugs. New mounting evidence is associating low vitamin D to diabetes mellitus and as such many studies were conducted to test the effect of vitamin D replacement on incidence of diabetes, diabetes control as well as diabetes complications. Although these studies present several limitations, vitamin D replacement seems to have beneficial effect on all aspects of diabetes: incidence, control and complications. Further longer term and more powered controlled trials are necessary to draw firmer conclusions on this beneficial role of vitamin D treatment on DM.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 62 条
[11]   Vitamin D decreases NFκB activity by increasing IκBα levels [J].
Cohen-Lahav, M ;
Shany, S ;
Tobvin, D ;
Chaimovitz, C ;
Douvdevani, A .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (04) :889-897
[12]   RETRACTED: The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages (Retracted article. See vol. 127, pg. 444, 2011) [J].
Cohen-Lahav, Merav ;
Douvdevani, Amos ;
Chaimovitz, Cidio ;
Shany, Shraga .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5) :558-562
[13]   Calcium plus vitamin D supplementation and the risk of incident diabetes in the women's health initiative [J].
de Boer, Ian H. ;
Tinker, Lesley F. ;
Connelly, Stephanie ;
Curb, J. David ;
Howard, Barbara V. ;
Kestenbaum, Bryan ;
Larson, Joseph C. ;
Manson, JoAnn E. ;
Margolis, Karen L. ;
Siscovick, David S. ;
Weiss, Noel S. .
DIABETES CARE, 2008, 31 (04) :701-707
[14]   Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial [J].
de Zeeuw, Dick ;
Agarwal, Rajiv ;
Amdahl, Michael ;
Audhya, Paul ;
Coyne, Daniel ;
Garimella, Tushar ;
Parving, Hans-Henrik ;
Pritchett, Yili ;
Remuzzi, Giuseppe ;
Ritz, Eberhard ;
Andress, Dennis .
LANCET, 2010, 376 (9752) :1543-1551
[15]   Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes [J].
Deb, Dilip K. ;
Sun, Tao ;
Wong, Kari E. ;
Zhang, Zhongyi ;
Ning, Gang ;
Zhang, Yan ;
Kong, Juan ;
Shi, Helen ;
Chang, Anthony ;
Li, Yan Chun .
KIDNEY INTERNATIONAL, 2010, 77 (11) :1000-1009
[16]  
DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S
[17]  
Eftekhari MH, 2011, ASIA PAC J CLIN NUTR, V20, P521
[18]   25 (OH) Vitamin D Levels and Renal Disease Progression in Patients with Type 2 Diabetic Nephropathy and Blockade of the Renin-Angiotensin System [J].
Fernandez-Juarez, Gema ;
Luno, Jose ;
Barrio, Vicente ;
Garcia de Vinuesa, Soledad ;
Praga, Manuel ;
Goicoechea, Marian ;
Lahera, Vicente ;
Casas, Luisa ;
Oliva, Jesus .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (11) :1870-1876
[19]   Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance - The Medical Research Council Ely Prospective Study 1990-2000 [J].
Forouhi, Nita G. ;
Luan, Jian'an ;
Cooper, Andrew ;
Boucher, Barbara J. ;
Wareham, Nicholas J. .
DIABETES, 2008, 57 (10) :2619-2625
[20]   1,25-dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: Implications for prevention of diabetes in nonobese diabetic mice [J].
Gysemans, CA ;
Cardozo, AK ;
Callewaert, H ;
Giulietti, A ;
Hulshagen, L ;
Bouillon, R ;
Eizirik, DL ;
Mathieu, C .
ENDOCRINOLOGY, 2005, 146 (04) :1956-1964